Clinical Trial Update: Treatment of Intrauterine Growth Restriction With Low Molecular Heparin. [Phase 3]

View source ↗

Summary

Phase 3 trial completed evaluating low molecular heparin for intrauterine growth restriction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrauterine Growth Restriction

Drugs mentioned

• Low molecular weight heparin (low molecular weight heparin)

Snippet

Sponsor: Fundació Sant Joan de Déu | Conditions: Intrauterine Growth Restriction | Phase 3 | Status: COMPLETED